Breakthrough could lead to personalized obesity treatments within a decade
Research by scientists at King’s College London into the role the gut plays in processing and distributing fat could pave the way for the development of personalised treatments for obesity and other chronic diseases within the next decade. The research is published in Nature Genetics.
In the largest study of its kind, scientists analysed the faecal metabolome (the community of chemicals produced by gut microbes in the faeces) of 500 pairs of twins to build up a picture of how the gut governs these processes and distributes fat. The King’s team also assessed how much of that activity is genetic and how much is determined by environmental factors.
The analysis of stool samples identified biomarkers for the build-up of internal fat around the waist. It’s well known that this visceral fat is strongly associated with the development of conditions including type 2 diabetes, heart disease and obesity.
By understanding how microbial chemicals lead to the development of fat around the waist in some, but not all the twins, the King’s team hopes to also advance the understanding of the very similar mechanisms that drive the development of obesity.
An analysis of faecal metabolites (chemical molecules in stool produced by microbes) found that less than a fifth (17.9 per cent) of gut processes could be attributed to hereditary factors, but 67.7 per cent of gut activity was found to be influenced by environmental factors, mainly a person’s regular diet.
This means that important changes can be made to the way an individual’s gut processes and distributes fat by altering both their diet and microbial interactions in their gut.
On the back of the study researchers have built a gut metabolome bank that can help other scientists engineer bespoke and ideal gut environments that efficiently process and distribute fat. The study has also generated the first comprehensive database of which microbes are associated with which chemical metabolites in the gut. This can help other scientists to understand how bacteria in the gut affect human health.
Lead investigator Dr Cristina Menni from King’s College London said: ‘This study has really accelerated our understanding of the interplay between what we eat, the way it is processed in the gut and the development of fat in the body, but also immunity and inflammation. By analysing the faecal metabolome, we have been able to get a snapshot of both the health of the body and the complex processes taking place in the gut.’
Head of the King’s College London’s Twin Research Group Professor Tim Spector said: ‘This exciting work in our twins shows the importance to our health and weight of the thousands of chemicals that gut microbes produce in response to food. Knowing that they are largely controlled by what we eat rather than our genes is great news, and opens up many ways to use food as medicine. In the future these chemicals could even be used in smart toilets or as smart toilet paper.’
Dr Jonas Zierer, first author of the study added: ‘This new knowledge means we can alter the gut environment and confront the challenge of obesity from a new angle that is related to modifiable factors such as diet and the microbes in the gut. This is exciting, because unlike our genes and our innate risk to develop fat around the belly, the gut microbes can be modified with probiotics, with drugs or with high fibre diets.’
Receive an email update when we add a new OBESITY article.
The Latest on: Personalized obesity treatments
via Google News
The Latest on: Personalized obesity treatments
- Forbion Portfolio Company Staten Biotechnology Enters into a Collaboration with Novo Nordisk to Develop Novel Treatment for D... on December 16, 2018 at 11:32 pm
Hypertriglyceridaemia is a serious risk factor for cardiovascular disease and is often present in people with diabetes and obesity. Staten Biotechnology has developed STT-5058, a new promising concept ... […]
- CRISPR Without the Chop Reverses Genetic Obesity in Mice on December 14, 2018 at 6:38 am
even many months after the single treatment. “These results demonstrate that CRISPRa can be used to up the dosage of genes in diseases that result from a missing copy, providing a potential cure for c... […]
- Global Anti-obesity Drugs Market (2018-2022): Analysis by Class of Obesity, Mechanism of Action and Region on December 6, 2018 at 12:41 am
Dublin, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The "Global Anti-obesity Drugs ... who offer obesity treatment drugs for mechanism such as centrally-acting and peripherally-acting anti-obesity drugs. Resear... […]
- Dietary fat: From foe to friend? on December 5, 2018 at 11:54 am
1 New Balance Foundation Obesity Prevention Center ... Can this knowledge inform personalized nutrition, with translation to prevention and treatment? 9. How does variation in the carbohydrate-to-fat ... […]
- Personalized ultrasound scan showing atherosclerosis helps reduce cardiovascular risk on December 3, 2018 at 9:03 pm
Personalized scans and depiction showing biological age and ... if needed according to clinical guidelines, pharmacological treatment. At one year follow up, the cardiovascular risk score for all part... […]
- Study finds that in treating obesity, one size does not fit all on November 13, 2018 at 4:24 am
At the extreme end of treatment—procedures such as ... Field added that obesity researchers need to test a variety of interventions in a more targeted, personalized manner. For example, mindfulness mi... […]
- Genetic obesity: next-generation sequencing results of 1230 patients with obesity on July 3, 2018 at 11:33 am
These findings show that the diagnostic obesity gene test can be useful in a clinical setting and could help these patients to receive (future) personalized treatment. (By Dr. Lotte Kleinendorst, http... […]
- Obesity is complex. Why aren’t its treatments? on March 5, 2017 at 8:38 pm
But doctors are trained to write prescriptions, not lifestyle plans. To get closer to the dream of personalized obesity treatments, we need more data—demographic, behavioral, environmental, socioecono... […]
- Personalized medicine may do more to treat rather than prevent chronic diseases on February 16, 2017 at 1:21 pm
But for complex, chronic diseases, relatively few personalized targeted treatments exist. Customizing treatments ... greater benefit in targeting prevention efforts to all people with obesity rather t... […]
via Bing News